Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs

Publication Date: July 31, 2021
Last Updated: March 14, 2022

In patients with stage IA NSCLC, image-guided thermal ablation is a safe and effective treatment with minimal complications and acceptable long-term oncological and survival outcomes that are comparable to SBRT and sublobar resection.

(C, Moderate)
328602

Image-guided thermal ablation is a safe and effective treatment option for patients with recurrent NSCLC.

(C, Moderate)
328602

Thermal ablation should be considered alongside surgical resection and SBRT in patients who require preservation of lung parenchyma function.

(C, Moderate)
328602

Image-guided thermal ablation of metastatic disease to the lungs may be appropriate in some patients, including those with a limited number of small (≤3 cm) lung metastases.

(C, Weak)
328602

RFA, CA, and MWA are all appropriate modalities for image-guided thermal ablation of primary or secondary lung tumors. The method of ablation should be determined by lesion characteristics and risk mitigation and should be left to the discretion of the operating physician.

(C, Weak)
328602

Biopsy of lung tumors is recommended before or during thermal ablation, when safe and possible.

(D, Weak)
328602

Future research in the form of comparative studies (either randomized controlled trials or well-conducted cohort studies) is required to strengthen the evidence base for image-guided thermal ablation in patients with inoperable stage I NSCLC, recurrent NSCLC, and metastatic lung disease.

(E, Moderate)
328602

Recommendation Grading

Overview

Title

Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs

Authoring Organization

Society of Interventional Radiology

Publication Month/Year

July 31, 2021

Last Updated Month/Year

April 1, 2024

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Inclusion Criteria

Female, Male, Adult, Older adult

Health Care Settings

Ambulatory, Home health, Hospital, Outpatient

Intended Users

Social worker, physician, nurse practitioner, nurse, physician assistant

Scope

Treatment

Diseases/Conditions (MeSH)

D002289 - Carcinoma, Non-Small-Cell Lung

Keywords

lung cancer, non-small-cell lung carcinoma (NSCLC), biopsy, thermal ablation, cryoablation, microwave ablation, radiofrequency ablation

Source Citation

Genshaft SJ, Suh RD, Abtin F, Baerlocher MO, Chang AJ, Dariushnia SR, Devane AM, Faintuch S, Himes EA, Lisberg A, Padia S, Patel S, Tam AL, Yanagawa J. Society of Interventional Radiology Multidisciplinary Position Statement on Percutaneous Ablation of Non-small Cell Lung Cancer and Metastatic Disease to the Lungs: Endorsed by the Canadian Association for Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, and the Society of Interventional Oncology. J Vasc Interv Radiol. 2021 Aug;32(8):1241.e1-1241.e12. doi: 10.1016/j.jvir.2021.04.024. PMID: 34332724.

Supplemental Methodology Resources

Data Supplement, Data Supplement

Methodology

Number of Source Documents
81
Literature Search Start Date
May 31, 1999
Literature Search End Date
May 31, 2019